ID   FANCF_HUMAN             Reviewed;         374 AA.
AC   Q9NPI8; Q52LM0;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   13-NOV-2019, entry version 157.
DE   RecName: Full=Fanconi anemia group F protein;
DE            Short=Protein FACF;
GN   Name=FANCF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INVOLVEMENT IN FANCF.
RX   PubMed=10615118; DOI=10.1038/71626;
RA   de Winter J.P., Rooimans M.A., van der Weel L., van Berkel C.G.M.,
RA   de Groot J., Waisfisz Q., Pronk J.C., Arwert F., Mathew C.G.,
RA   Scheper R.J., Hoatlin M.E., Buchwald M., Joenje H.;
RT   "The Fanconi anaemia gene FANCF encodes a novel protein with homology
RT   to ROM.";
RL   Nat. Genet. 24:15-16(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LEU-320.
RG   NIEHS SNPs program;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE, IDENTIFICATION BY MASS SPECTROMETRY, X-RAY
RP   CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 156-357, MUTAGENESIS OF LEU-209;
RP   PHE-251; TYR-287; LEU-289; PHE-339; VAL-341 AND LEU-344, AND SUBUNIT.
RX   PubMed=17082180; DOI=10.1074/jbc.m608356200;
RA   Kowal P., Gurtan A.M., Stuckert P., D'Andrea A.D., Ellenberger T.;
RT   "Structural determinants of human FANCF protein that function in the
RT   assembly of a DNA damage signaling complex.";
RL   J. Biol. Chem. 282:2047-2055(2007).
RN   [6]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=11063725; DOI=10.1093/hmg/9.18.2665;
RA   de Winter J.P., van der Weel L., de Groot J., Stone S., Waisfisz Q.,
RA   Arwert F., Scheper R.J., Kruyt F.A.E., Hoatlin M.E., Joenje H.;
RT   "The Fanconi anemia protein FANCF forms a nuclear complex with FANCA,
RT   FANCC and FANCG.";
RL   Hum. Mol. Genet. 9:2665-2674(2000).
RN   [7]
RP   IDENTIFICATION IN A COMPLEX WITH FANCA; FANCC; FANCE; FANCG AND FANCL.
RX   PubMed=12724401; DOI=10.1128/mcb.23.10.3417-3426.2003;
RA   Meetei A.R., Sechi S., Wallisch M., Yang D., Young M.K., Joenje H.,
RA   Hoatlin M.E., Wang W.;
RT   "A multiprotein nuclear complex connects Fanconi anemia and Bloom
RT   syndrome.";
RL   Mol. Cell. Biol. 23:3417-3426(2003).
RN   [8]
RP   IDENTIFICATION IN A COMPLEX WITH FANCA; FANCB; FANCC; FANCE; FANCG AND
RP   FANCL.
RX   PubMed=15502827; DOI=10.1038/ng1458;
RA   Meetei A.R., Levitus M., Xue Y., Medhurst A.L., Zwaan M., Ling C.,
RA   Rooimans M.A., Bier P., Hoatlin M., Pals G., de Winter J.P., Wang W.,
RA   Joenje H.;
RT   "X-linked inheritance of Fanconi anemia complementation group B.";
RL   Nat. Genet. 36:1219-1224(2004).
RN   [9]
RP   IDENTIFICATION IN A COMPLEX WITH FANCA; FANCB; FANCC; FANCE; FANCG;
RP   FANCL AND FANCM.
RX   PubMed=16116422; DOI=10.1038/ng1626;
RA   Meetei A.R., Medhurst A.L., Ling C., Xue Y., Singh T.R., Bier P.,
RA   Steltenpool J., Stone S., Dokal I., Mathew C.G., Hoatlin M.,
RA   Joenje H., de Winter J.P., Wang W.;
RT   "A human ortholog of archaeal DNA repair protein Hef is defective in
RT   Fanconi anemia complementation group M.";
RL   Nat. Genet. 37:958-963(2005).
RN   [10]
RP   INTERACTION WITH HES1, AND SUBCELLULAR LOCATION.
RX   PubMed=18550849; DOI=10.1182/blood-2008-04-152710;
RA   Tremblay C.S., Huang F.F., Habi O., Huard C.C., Godin C., Levesque G.,
RA   Carreau M.;
RT   "HES1 is a novel interactor of the Fanconi anemia core complex.";
RL   Blood 112:2062-2070(2008).
CC   -!- FUNCTION: DNA repair protein that may operate in a postreplication
CC       repair or a cell cycle checkpoint function. May be implicated in
CC       interstrand DNA cross-link repair and in the maintenance of normal
CC       chromosome stability (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Belongs to the multisubunit FA complex composed of FANCA,
CC       FANCB, FANCC, FANCE, FANCF, FANCG, FANCL/PHF9 and FANCM. The
CC       complex is not found in FA patients. In complex with FANCA, FANCG
CC       and FANCL, but not with FANCC, nor FANCE, interacts with HES1;
CC       this interaction may be essential for the stability and nuclear
CC       localization of FA core complex proteins.
CC       {ECO:0000269|PubMed:11063725, ECO:0000269|PubMed:12724401,
CC       ECO:0000269|PubMed:15502827, ECO:0000269|PubMed:16116422,
CC       ECO:0000269|PubMed:17082180, ECO:0000269|PubMed:18550849}.
CC   -!- INTERACTION:
CC       O15360:FANCA; NbExp=5; IntAct=EBI-81589, EBI-81570;
CC       O15287:FANCG; NbExp=4; IntAct=EBI-81589, EBI-81610;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11063725,
CC       ECO:0000269|PubMed:18550849}.
CC   -!- DISEASE: Fanconi anemia complementation group F (FANCF)
CC       [MIM:603467]: A disorder affecting all bone marrow elements and
CC       resulting in anemia, leukopenia and thrombopenia. It is associated
CC       with cardiac, renal and limb malformations, dermal pigmentary
CC       changes, and a predisposition to the development of malignancies.
CC       At the cellular level it is associated with hypersensitivity to
CC       DNA-damaging agents, chromosomal instability (increased chromosome
CC       breakage) and defective DNA repair. {ECO:0000269|PubMed:10615118}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FANCFID294.html";
CC   -!- WEB RESOURCE: Name=Fanconi Anemia Mutation Database;
CC       URL="http://www2.rockefeller.edu/fanconi/genes/jumpf";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/fancf/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF181995; AAF26298.1; -; mRNA.
DR   EMBL; AF181994; AAF26297.1; -; mRNA.
DR   EMBL; AK023153; BAB14433.1; -; mRNA.
DR   EMBL; AY928335; AAX09677.1; -; Genomic_DNA.
DR   EMBL; BC047028; AAH47028.1; -; mRNA.
DR   EMBL; BC093867; AAH93867.1; -; mRNA.
DR   EMBL; BC101807; AAI01808.1; -; mRNA.
DR   CCDS; CCDS7857.1; -.
DR   RefSeq; NP_073562.1; NM_022725.3.
DR   PDB; 2IQC; X-ray; 2.40 A; A=156-357.
DR   PDBsum; 2IQC; -.
DR   SMR; Q9NPI8; -.
DR   BioGrid; 108483; 20.
DR   CORUM; Q9NPI8; -.
DR   IntAct; Q9NPI8; 11.
DR   MINT; Q9NPI8; -.
DR   STRING; 9606.ENSP00000330875; -.
DR   BindingDB; Q9NPI8; -.
DR   ChEMBL; CHEMBL2157856; -.
DR   MoonDB; Q9NPI8; Predicted.
DR   iPTMnet; Q9NPI8; -.
DR   PhosphoSitePlus; Q9NPI8; -.
DR   BioMuta; FANCF; -.
DR   DMDM; 23821547; -.
DR   EPD; Q9NPI8; -.
DR   jPOST; Q9NPI8; -.
DR   MassIVE; Q9NPI8; -.
DR   MaxQB; Q9NPI8; -.
DR   PaxDb; Q9NPI8; -.
DR   PeptideAtlas; Q9NPI8; -.
DR   PRIDE; Q9NPI8; -.
DR   ProteomicsDB; 82022; -.
DR   Ensembl; ENST00000327470; ENSP00000330875; ENSG00000183161.
DR   GeneID; 2188; -.
DR   KEGG; hsa:2188; -.
DR   UCSC; uc001mql.2; human.
DR   CTD; 2188; -.
DR   DisGeNET; 2188; -.
DR   GeneCards; FANCF; -.
DR   GeneReviews; FANCF; -.
DR   HGNC; HGNC:3587; FANCF.
DR   MalaCards; FANCF; -.
DR   MIM; 603467; phenotype.
DR   MIM; 613897; gene.
DR   neXtProt; NX_Q9NPI8; -.
DR   OpenTargets; ENSG00000183161; -.
DR   Orphanet; 84; Fanconi anemia.
DR   PharmGKB; PA28001; -.
DR   eggNOG; ENOG410IKQV; Eukaryota.
DR   eggNOG; ENOG4111WMC; LUCA.
DR   GeneTree; ENSGT00390000005623; -.
DR   InParanoid; Q9NPI8; -.
DR   KO; K10893; -.
DR   OMA; WARYLRH; -.
DR   OrthoDB; 1404593at2759; -.
DR   PhylomeDB; Q9NPI8; -.
DR   TreeFam; TF332957; -.
DR   Reactome; R-HSA-6783310; Fanconi Anemia Pathway.
DR   SIGNOR; Q9NPI8; -.
DR   ChiTaRS; FANCF; human.
DR   EvolutionaryTrace; Q9NPI8; -.
DR   GeneWiki; FANCF; -.
DR   GenomeRNAi; 2188; -.
DR   Pharos; Q9NPI8; -.
DR   PRO; PR:Q9NPI8; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000183161; Expressed in 182 organ(s), highest expression level in forebrain.
DR   ExpressionAtlas; Q9NPI8; baseline and differential.
DR   Genevisible; Q9NPI8; HS.
DR   GO; GO:0043240; C:Fanconi anaemia nuclear complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IBA:GO_Central.
DR   GO; GO:0036297; P:interstrand cross-link repair; TAS:Reactome.
DR   Gene3D; 1.25.40.490; -; 1.
DR   InterPro; IPR035428; FANCF.
DR   InterPro; IPR038505; FANCF_C_sf.
DR   PANTHER; PTHR14449; PTHR14449; 1.
DR   Pfam; PF11107; FANCF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   DNA damage; DNA repair; Fanconi anemia; Nucleus; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    374       Fanconi anemia group F protein.
FT                                /FTId=PRO_0000087188.
FT   VARIANT     295    295       V -> I (in dbSNP:rs7103293).
FT                                /FTId=VAR_050988.
FT   VARIANT     320    320       P -> L (in dbSNP:rs45451294).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_022270.
FT   MUTAGEN     209    209       L->R: Reduced monoubiquitination of
FT                                FANCD2. {ECO:0000269|PubMed:17082180}.
FT   MUTAGEN     251    251       F->R: Reduced monoubiquitination of
FT                                FANCD2. {ECO:0000269|PubMed:17082180}.
FT   MUTAGEN     287    287       Y->A: Strongly reduced monoubiquitination
FT                                of FANCD2; when associated with A-289; A-
FT                                339; A-341 and A-344.
FT                                {ECO:0000269|PubMed:17082180}.
FT   MUTAGEN     289    289       L->A: Strongly reduced monoubiquitination
FT                                of FANCD2; when associated with A-287; A-
FT                                339; A-341 and A-344.
FT                                {ECO:0000269|PubMed:17082180}.
FT   MUTAGEN     339    339       F->A: Strongly reduced monoubiquitination
FT                                of FANCD2; when associated with A-287; A-
FT                                289; A-341 and A-344.
FT                                {ECO:0000269|PubMed:17082180}.
FT   MUTAGEN     341    341       V->A: Strongly reduced monoubiquitination
FT                                of FANCD2; when associated with A-287; A-
FT                                289; A-339 and A-344.
FT                                {ECO:0000269|PubMed:17082180}.
FT   MUTAGEN     344    344       L->A: Strongly reduced monoubiquitination
FT                                of FANCD2; when associated with A-287; A-
FT                                289; A-339 and A-341.
FT                                {ECO:0000269|PubMed:17082180}.
FT   HELIX       160    174       {ECO:0000244|PDB:2IQC}.
FT   HELIX       186    195       {ECO:0000244|PDB:2IQC}.
FT   HELIX       198    209       {ECO:0000244|PDB:2IQC}.
FT   HELIX       235    243       {ECO:0000244|PDB:2IQC}.
FT   HELIX       245    254       {ECO:0000244|PDB:2IQC}.
FT   HELIX       257    266       {ECO:0000244|PDB:2IQC}.
FT   HELIX       268    270       {ECO:0000244|PDB:2IQC}.
FT   HELIX       271    283       {ECO:0000244|PDB:2IQC}.
FT   STRAND      286    288       {ECO:0000244|PDB:2IQC}.
FT   TURN        289    292       {ECO:0000244|PDB:2IQC}.
FT   STRAND      293    295       {ECO:0000244|PDB:2IQC}.
FT   HELIX       304    315       {ECO:0000244|PDB:2IQC}.
FT   HELIX       319    335       {ECO:0000244|PDB:2IQC}.
FT   HELIX       346    354       {ECO:0000244|PDB:2IQC}.
SQ   SEQUENCE   374 AA;  42254 MW;  1F295CD1FBE6ED7D CRC64;
     MESLLQHLDR FSELLAVSST TYVSTWDPAT VRRALQWARY LRHIHRRFGR HGPIRTALER
     RLHNQWRQEG GFGRGPVPGL ANFQALGHCD VLLSLRLLEN RALGDAARYH LVQQLFPGPG
     VRDADEETLQ ESLARLARRR SAVHMLRFNG YRENPNLQED SLMKTQAELL LERLQEVGKA
     EAERPARFLS SLWERLPQNN FLKVIAVALL QPPLSRRPQE ELEPGIHKSP GEGSQVLVHW
     LLGNSEVFAA FCRALPAGLL TLVTSRHPAL SPVYLGLLTD WGQRLHYDLQ KGIWVGTESQ
     DVPWEELHNR FQSLCQAPPP LKDKVLTALE TCKAQDGDFE VPGLSIWTDL LLALRSGAFR
     KRQVLGLSAG LSSV
//